The hypothesis is that inflammation in the brain increases the risk of AD by producing amyloid beta peptide (Aβ), observed in the presence of senile extracellular amyloid plaques (APs), and the formation of neurofibrillary tangles (NFTs) due to the buildup of hyperphosphorylated tau protein. The gene discussed is APP; the disease is Alzheimer disease.